ConductScience.org, home

Trial · NCT02352831

Adverse events130

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEvents
otherAnemiaBlood and lymphatic system disordersPhase I (Tosedostat + Capecitabine)16
otherAnemiaBlood and lymphatic system disordersPhase II (Tosedostat + Capecitabine)210
otherBlurred visionEye disordersPhase I (Tosedostat + Capecitabine)06
otherBlurred visionEye disordersPhase II (Tosedostat + Capecitabine)210
otherDry eyeEye disordersPhase I (Tosedostat + Capecitabine)06
otherDry eyeEye disordersPhase II (Tosedostat + Capecitabine)110
otherAbdominal painGastrointestinal disordersPhase I (Tosedostat + Capecitabine)06
otherAbdominal painGastrointestinal disordersPhase II (Tosedostat + Capecitabine)310
otherConstipationGastrointestinal disordersPhase I (Tosedostat + Capecitabine)16
otherConstipationGastrointestinal disordersPhase II (Tosedostat + Capecitabine)010
otherDiarrheaGastrointestinal disordersPhase I (Tosedostat + Capecitabine)26
otherDiarrheaGastrointestinal disordersPhase II (Tosedostat + Capecitabine)510
otherDyspepsiaGastrointestinal disordersPhase I (Tosedostat + Capecitabine)16
otherDyspepsiaGastrointestinal disordersPhase II (Tosedostat + Capecitabine)310
otherDysphagiaGastrointestinal disordersPhase I (Tosedostat + Capecitabine)16
otherDysphagiaGastrointestinal disordersPhase II (Tosedostat + Capecitabine)010
otherFlatulenceGastrointestinal disordersPhase I (Tosedostat + Capecitabine)16
otherFlatulenceGastrointestinal disordersPhase II (Tosedostat + Capecitabine)010
otherMucositis-oralGastrointestinal disordersPhase I (Tosedostat + Capecitabine)16
otherMucositis-oralGastrointestinal disordersPhase II (Tosedostat + Capecitabine)110

Source ClinicalTrials.govtrials-2026-11-12-0.4.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNone stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02352831/events